Ensuring Best Outcomes for Children with Behavioral Needs and Adults with Medical Fragility in a Congregate Care Setting Amidst the COVID-19 Pandemic

COVID-19 abruptly thrust new challenges onto organizations providing intensive behavioral services in a congregate care setting to individuals diagnosed with intellectual and developmental disabilities. The novel virus and its many unknowns required organizations to respond to a rapidly evolving...

Integrated Psychiatry for Individuals with Developmental Disabilities

Use of psychotropic drugs for individuals with developmental disabilities is common practice. For example, Jobski, Hofer, Hoffman, and Bachmann (2016) documented an overall median use of psychotropic drugs in 45.7% of individuals with autism spectrum disorder (ASD). Wink et al., (2018) documented...